Foresight Group Ltd Liability Partnership Sells 232,808 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Foresight Group Ltd Liability Partnership cut its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 16.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 1,219,388 shares of the real estate investment trust’s stock after selling 232,808 shares during the period. Healthpeak Properties accounts for about 14.7% of Foresight Group Ltd Liability Partnership’s investment portfolio, making the stock its 2nd largest holding. Foresight Group Ltd Liability Partnership’s holdings in Healthpeak Properties were worth $24,717,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of DOC. JPMorgan Chase & Co. increased its holdings in Healthpeak Properties by 23.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after buying an additional 4,056,931 shares during the period. Thrivent Financial for Lutherans bought a new stake in Healthpeak Properties in the 3rd quarter valued at $1,880,000. Swedbank AB bought a new stake in Healthpeak Properties in the 3rd quarter valued at $1,832,000. Pathstone Holdings LLC bought a new stake in Healthpeak Properties in the 3rd quarter valued at $1,968,000. Finally, Associated Banc Corp bought a new stake in Healthpeak Properties in the 3rd quarter valued at $10,559,000. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Trading Up 1.8 %

DOC opened at $20.69 on Friday. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.31 and a quick ratio of 1.31. The company has a market cap of $14.47 billion, a price-to-earnings ratio of 44.03, a price-to-earnings-growth ratio of 2.12 and a beta of 1.14. The firm has a 50 day simple moving average of $20.94 and a 200 day simple moving average of $21.48. Healthpeak Properties, Inc. has a fifty-two week low of $16.01 and a fifty-two week high of $23.26.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). The business had revenue of $700.40 million for the quarter, compared to the consensus estimate of $682.51 million. Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The company’s quarterly revenue was up 25.9% on a year-over-year basis. During the same period last year, the firm earned $0.45 earnings per share. On average, sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.81 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 5.80%. The ex-dividend date of this dividend was Monday, November 4th. Healthpeak Properties’s dividend payout ratio (DPR) is currently 255.32%.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on DOC shares. Wells Fargo & Company cut their target price on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft upgraded Healthpeak Properties from a “hold” rating to a “buy” rating and raised their target price for the stock from $20.00 to $28.00 in a research report on Monday, October 21st. Robert W. Baird raised their target price on Healthpeak Properties from $24.00 to $25.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Mizuho cut their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. Finally, Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price for the company in a research report on Wednesday. One research analyst has rated the stock with a sell rating, three have given a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.15.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.